Jiangxi Bio Unit Wins China Nod for Veterinary Tetanus Antitoxin
Jiangxi Institute of Biological Products' (HKG:6915) wholly owned subsidiary, Chifeng Bo-en Pharmaceutical, received an approval certificate from Chinese regulators for its veterinary tetanus antitoxin, according to a Friday Hong Kong bourse filing. The product is used to prevent and treat tetanus infections in animals by neutralizing tetanus toxin and providing passive immune protection to animals at risk of infection.
Jiangxi Institute of Biological Products' (HKG:6915) wholly owned subsidiary, Chifeng Bo-en Pharmaceutical, received an approval certificate from Chinese regulators for its veterinary tetanus antitoxin, according to a Friday Hong Kong bourse filing.
The product is used to prevent and treat tetanus infections in animals by neutralizing tetanus toxin and providing passive immune protection to animals at risk of infection.